Benefits Canada Live: Drug innovations webinar series: Every minute counts in treating a rare blood medical emergency

New specialty drugs deliver patient benefits, but also impact private health benefits plans. Stay on top of new drug introductions by attending Benefits Canada’s drug innovations webinars, where you’ll hear directly from experts about new medications and the diseases they treat. aTTP (acquired Thrombotic Thrombocytopenic Purpura) is a rare, life-threatening emergency blood disorder that typically occurs in the young, working population and has serious long-term impacts if not treated quickly. This webinar helped attendees better understand how aTTP and the first targeted therapy approved for this condition may impact benefits plans.


Date: Thursday, June 25, 2020

Cassandra Williamson-Hopp, conference editor, Benefits Canada

Dr. Louis Girard,
nephrologist and clinical associate professor, University of Calgary
Dr. Rahul Bohra,
medical science liaison for rare blood disorders, Sanofi Genzyme